These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 23619898)
1. Assessment of the novel estrogen receptor PET tracer 4-fluoro-11β-methoxy-16α-[(18)F]fluoroestradiol (4FMFES) by PET imaging in a breast cancer murine model. Paquette M; Phoenix S; Ouellet R; Langlois R; van Lier JE; Turcotte EE; Bénard F; Lecomte R Mol Imaging Biol; 2013 Oct; 15(5):625-32. PubMed ID: 23619898 [TBL] [Abstract][Full Text] [Related]
2. [18F]-fluoroestradiol quantitative PET imaging to differentiate ER+ and ERα-knockdown breast tumors in mice. Paquette M; Ouellet R; Archambault M; Croteau É; Lecomte R; Bénard F Nucl Med Biol; 2012 Jan; 39(1):57-64. PubMed ID: 22079037 [TBL] [Abstract][Full Text] [Related]
3. Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer Paquette M; Lavallée É; Phoenix S; Ouellet R; Senta H; van Lier JE; Guérin B; Lecomte R; Turcotte ÉE J Nucl Med; 2018 Feb; 59(2):197-203. PubMed ID: 28798032 [TBL] [Abstract][Full Text] [Related]
4. Cross-Species Physiological Assessment of Brain Estrogen Receptor Expression Using Paquette M; Phoenix S; Lavallée É; Rousseau JA; Guérin B; Turcotte ÉE; Lecomte R Mol Imaging Biol; 2020 Oct; 22(5):1403-1413. PubMed ID: 32699974 [TBL] [Abstract][Full Text] [Related]
5. A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts. Paquette M; Phoenix S; Lawson C; Guérin B; Lecomte R; Tai LH; Turcotte ÉE; Leyton JV EJNMMI Res; 2020 Jun; 10(1):69. PubMed ID: 32592121 [TBL] [Abstract][Full Text] [Related]
6. [18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice. Bénard F; Ahmed N; Beauregard JM; Rousseau J; Aliaga A; Dubuc C; Croteau E; van Lier JE Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1473-9. PubMed ID: 18360749 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging. Aliaga A; Rousseau JA; Ouellette R; Cadorette J; van Lier JE; Lecomte R; Bénard F Nucl Med Biol; 2004 Aug; 31(6):761-70. PubMed ID: 15246367 [TBL] [Abstract][Full Text] [Related]
8. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT. Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905 [TBL] [Abstract][Full Text] [Related]
9. Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer. Fowler AM; Chan SR; Sharp TL; Fettig NM; Zhou D; Dence CS; Carlson KE; Jeyakumar M; Katzenellenbogen JA; Schreiber RD; Welch MJ J Nucl Med; 2012 Jul; 53(7):1119-26. PubMed ID: 22669982 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader. Heidari P; Deng F; Esfahani SA; Leece AK; Shoup TM; Vasdev N; Mahmood U Clin Cancer Res; 2015 Mar; 21(6):1340-7. PubMed ID: 25609068 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 7α-(3-[(18)F]fluoropropyl) estradiol. Okamoto M; Naka K; Kitagawa Y; Ishiwata K; Yoshimoto M; Shimizu I; Toyohara J Nucl Med Biol; 2015 Jul; 42(7):590-7. PubMed ID: 25823392 [TBL] [Abstract][Full Text] [Related]
13. Xu D; Zhuang R; You L; Guo Z; Wang X; Peng C; Zhang D; Zhang P; Wu H; Pan W; Zhang X Nucl Med Biol; 2018 Apr; 59():48-55. PubMed ID: 29466767 [TBL] [Abstract][Full Text] [Related]
14. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[ Katzenellenbogen JA Nucl Med Biol; 2021 Jan; 92():24-37. PubMed ID: 32229068 [TBL] [Abstract][Full Text] [Related]
15. Assessment of estrogen receptor expression in epithelial ovarian cancer patients using 16α-18F-fluoro-17β-estradiol PET/CT. van Kruchten M; de Vries EF; Arts HJ; Jager NM; Bongaerts AH; Glaudemans AW; Hollema H; de Vries EG; Hospers GA; Reyners AK J Nucl Med; 2015 Jan; 56(1):50-5. PubMed ID: 25476534 [TBL] [Abstract][Full Text] [Related]
16. Kumar M; Salem K; Michel C; Jeffery JJ; Yan Y; Fowler AM J Nucl Med; 2019 Sep; 60(9):1247-1252. PubMed ID: 30850489 [TBL] [Abstract][Full Text] [Related]
17. 18F-labeled difluoroestradiols: preparation and preclinical evaluation as estrogen receptor-binding radiopharmaceuticals. Seimbille Y; Rousseau J; Bénard F; Morin C; Ali H; Avvakumov G; Hammond GL; van Lier JE Steroids; 2002 Aug; 67(9):765-75. PubMed ID: 12123788 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal Molecular Imaging of Progesterone Receptor Reveals Early Differential Response to Endocrine Therapy in Breast Cancer with an Activating Kumar M; Salem K; Jeffery JJ; Yan Y; Mahajan AM; Fowler AM J Nucl Med; 2021 Apr; 62(4):500-506. PubMed ID: 32859700 [TBL] [Abstract][Full Text] [Related]
19. Biodistribution of Iqbal R; Yaqub M; Oprea-Lager DE; Liu Y; Luik AM; Beelen AP; Schuit RC; Windhorst AD; Boellaard R; Menke-van der Houven van Oordt CW J Nucl Med; 2022 May; 63(5):694-699. PubMed ID: 34446451 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and Evaluation of the Estrogen Receptor β-Selective Radioligand 2- Antunes IF; van Waarde A; Dierckx RA; de Vries EG; Hospers GA; de Vries EF J Nucl Med; 2017 Apr; 58(4):554-559. PubMed ID: 27908969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]